Cleveland BioLabs, Inc. (NASDAQ:CBLI)

CAPS Rating: 3 out of 5

The Company is engaged in the discovery, development and commercialization of products for cancer treatment and protection of normal tissues from radiation and toxins.

Recs

0
Player Avatar hyronx (< 20) Submitted: 2/27/2007 6:31:08 PM : Outperform Start Price: $9.47 CBLI Score: -86.14

This stock went way up since New Year 2007 and made up to 150%

Featured Broker Partners


Advertisement